117 related articles for article (PubMed ID: 24314882)
1. Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21.
Stein JJ; Iwuchukwu C; Maier KG; Gahtan V
Surgery; 2014 Feb; 155(2):228-33. PubMed ID: 24314882
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1-induced smooth muscle cell chemotaxis and proliferation are dependent on transforming growth factor-β2 and hyaluronic acid synthase.
Stein JJ; Iwuchukwu C; Maier KG; Gahtan V
Mol Cell Biochem; 2013 Dec; 384(1-2):181-6. PubMed ID: 24104451
[TBL] [Abstract][Full Text] [Related]
3. The role of G proteins in thromospondin-1-induced vascular smooth muscle cell migration.
Fuse S; Esemuede N; Yamaguchi M; Maier KG; Nesselroth SM; Sumpio BE; Gahtan V
Surgery; 2008 Jul; 144(1):86-92. PubMed ID: 18571589
[TBL] [Abstract][Full Text] [Related]
4. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
Helkin A; Maier KG; Gahtan V
Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 differentially regulates microRNAs in vascular smooth muscle cells.
Maier KG; Ruhle B; Stein JJ; Gentile KL; Middleton FA; Gahtan V
Mol Cell Biochem; 2016 Jan; 412(1-2):111-7. PubMed ID: 26728995
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44.
Maier KG; Sadowitz B; Cullen S; Han X; Gahtan V
Am J Surg; 2009 Nov; 198(5):664-9. PubMed ID: 19887196
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1: a proatherosclerotic protein augmented by hyperglycemia.
Maier KG; Han X; Sadowitz B; Gentile KL; Middleton FA; Gahtan V
J Vasc Surg; 2010 May; 51(5):1238-47. PubMed ID: 20299182
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1 induces matrix metalloproteinase-2 activation in vascular smooth muscle cells.
Lee T; Esemuede N; Sumpio BE; Gahtan V
J Vasc Surg; 2003 Jul; 38(1):147-54. PubMed ID: 12844104
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: the role of the type 3 repeat and carboxyl terminal domains.
Lee T; Nesselroth SM; Olson ET; Esemuede N; Lawler J; Sumpio BE; Gahtan V
J Cell Biochem; 2003 Jun; 89(3):500-6. PubMed ID: 12761883
[TBL] [Abstract][Full Text] [Related]
12. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
Zhang Y; Chen X
Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.
Seymour KA; Sadowitz B; Stein JJ; Lawler J; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):553-7. PubMed ID: 21906719
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
Wang J; Yan CH; Li Y; Xu K; Tian XX; Peng CF; Tao J; Sun MY; Han YL
Exp Cell Res; 2013 May; 319(8):1165-75. PubMed ID: 23518389
[TBL] [Abstract][Full Text] [Related]
15. The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin.
Stein JJ; Seymour KA; Maier KG; Gahtan V
Am J Surg; 2011 Nov; 202(5):545-8. PubMed ID: 21944292
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal domain of thrombospondin-1 induces vascular smooth muscle cell chemotaxis.
Nesselroth SM; Willis AI; Fuse S; Olson ET; Lawler J; Sumpio BE; Gahtan V
J Vasc Surg; 2001 Mar; 33(3):595-600. PubMed ID: 11241132
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis.
Willis AI; Fuse S; Wang XJ; Chen E; Tuszynski GP; Sumpio BE; Gahtan V
J Vasc Surg; 2000 Jun; 31(6):1160-7. PubMed ID: 10842153
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury.
Iaconetti C; Polimeni A; Sorrentino S; Sabatino J; Pironti G; Esposito G; Curcio A; Indolfi C
Basic Res Cardiol; 2012 Sep; 107(5):296. PubMed ID: 22890560
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor stimulates a novel calcium-signaling pathway in vascular smooth muscle cells.
Chandra A; Angle N
Surgery; 2005 Oct; 138(4):780-7. PubMed ID: 16269309
[TBL] [Abstract][Full Text] [Related]
20. l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty.
Yokouchi K; Numaguchi Y; Kubota R; Ishii M; Imai H; Murakami R; Ogawa Y; Kondo T; Okumura K; Ingber DE; Murohara T
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2231-7. PubMed ID: 16888241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
